<DOC>
	<DOCNO>NCT01730365</DOCNO>
	<brief_summary>Investigation application possibility optical spectroscopy within field oncology . Optical spectroscopy enables possibility specifically differentiate different ( human ) tissue . The hypothesis incorporation technique exist medical device ( e.g . biopsy needle ) would enlarge accuracy reliability device . The purpose improve speed diagnostics therapy malignancy .</brief_summary>
	<brief_title>Optical Detection Malignancy During Percutaneous Interventions</brief_title>
	<detailed_description>Primary Objective : In observational study investigator aim evaluate whether optical spectroscopy correctly diagnose malignant tissue exist clinical workflow percutaneous intervention lung , liver , breast . Secondary Objective : During measurement procedure , possible improvement measurement hardware record . Analysis documentation provide information possible alteration hardware design improved clinical applicability future . Special attention pay observe procedure fit standard workflow radiologist .</detailed_description>
	<mesh_term>Solitary Pulmonary Nodule</mesh_term>
	<criteria>Patients suspicious lesion lung liver schedule standard core biopsy procedure Patient plan percutaneous RFA colorectal liver metastasis Written inform consent Patients â‰¥ 18 year old Breast patient BIRADS score 4 5 General Exclusion criterion : Patients high risk bleed Patients suspected sensitivity light ; e.g . patient photodynamic therapy Breast Specific Exclusion criterion : Patients history breast cancer and/or receive prior chemotherapy , endocrine therapy , radiation therapy Patients breast implant Patients need stereotactic breast biopsy ( i.e . non palpable , ultrasound opaque lesion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>spectroscopy</keyword>
	<keyword>tumour</keyword>
	<keyword>biopsy</keyword>
	<keyword>malignancy</keyword>
</DOC>